Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Hair loss can be caused by stress, aging, and harmful substances that create an imbalance in the body's natural processes.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

The study created a new method to test drugs that affect hormone processing in skin.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Excess androgens may cause PCOS, not just be a symptom.